Endolaryngeal surgery in treatment of early-stage cancer in supraglottic laryngeal region
- Authors: Stadler V.V.1,2, Mahonin A.A.1,2, Gabrielyan A.G.1,2, Sinotin A.I.3, Postnikov M.А.1, Vladimirova T.Y.1, Kostin D.S.3
-
Affiliations:
- Samara State Medical University
- Samara Regional Clinical Oncology
- Samara Regional Clinical Oncology Center
- Issue: Vol 5, No 4 (2020)
- Pages: 258-261
- Section: Oncology
- URL: https://ogarev-online.ru/2500-1388/article/view/53089
- DOI: https://doi.org/10.35693/2500-1388-2020-5-4-258-261
- ID: 53089
Cite item
Full Text
Abstract
Objectives – to improve the results of surgical treatment of patients with T1-T2 stages of cancer in the supraglottic and ventricular region by using endolaryngeal resections.
Material and methods. The study was held in Samara Regional Clinical Oncology Center from 2011 to 2016. We analysed 97 case histories of patients diagnosed with stage 0-I laryngeal cancer. The patients were divided into 2 groups depending on the selected organ-preserving method of surgical treatment. The patients of the control group were subjected to open resection of the larynx (laryngofissure). While the patients of the main group received the endolaryngeal resection using an endoscopic rack, a suspension system, a laryngoscope, hard endoscopes of 0, 30, 45 degrees, as well as electrosurgical cutting and endolaryngeal instruments.
Results. The duration of the operation, blood loss, and bed day number was significantly less in patients of the main group in comparison with the control group. Also, the percentage of common complications in the main group was lower in relation to the control group. The three-year relapse-free and overall survival was not significantly different between the study groups.
Conclusion. According to our observations, the endolaryngeal resections in treatment of the initial stages of laryngeal cancer do not impair the results of treatment and do not significantly affect the survival of this category of patients.
Keywords
Full Text
##article.viewOnOriginalSite##About the authors
V. V. Stadler
Samara State Medical University; Samara Regional Clinical Oncology
Email: Gabriel_002@mail.ru
ORCID iD: 0000-0002-5134-0668
PhD, Associate Professor, Department of Ambulance anesthesiology and resuscitation, IPE; Head of the Anesthesiology and resuscitation Department
Russian Federation, SamaraA. A. Mahonin
Samara State Medical University; Samara Regional Clinical Oncology
Email: Gabriel_002@mail.ru
assistant of the Otorhinolaryngology Department n.a. acad. I.B. Soldatov; the Head of the Department of neck and head tumors
Russian Federation, SamaraA. G. Gabrielyan
Samara State Medical University; Samara Regional Clinical Oncology
Author for correspondence.
Email: Gabriel_002@mail.ru
ORCID iD: 0000-0002-5321-6070
assistant of the Department of Dentistry, IPE, maxillofacial surgeon
Russian Federation, SamaraA. I. Sinotin
Samara Regional Clinical Oncology Center
Email: Gabriel_002@mail.ru
ORCID iD: 0000-0001-9641-2349
oncologist
Russian Federation, SamaraM. А. Postnikov
Samara State Medical University
Email: Gabriel_002@mail.ru
ORCID iD: 0000-0002-2232-8870
PhD, Associate Professor, Head of the Department of Dentistry, IPE
Russian Federation, SamaraT. Yu. Vladimirova
Samara State Medical University
Email: Gabriel_002@mail.ru
ORCID iD: 0000-0001-9797-3172
PhD, Associate Professor, Head of the Otorhinolaryngology Department and Clinic n.a. acad. I.B. Soldatov
Russian Federation, SamaraD. S. Kostin
Samara Regional Clinical Oncology Center
Email: Gabriel_002@mail.ru
ORCID iD: 0000-0001-9797-3172
anesthesiologist-reanimatologist
Russian Federation, SamaraSupplementary files
